Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$63.96
Market cap
$222.4M
P/E Ratio
14.77
Dividend/share
$1.2
EPS
$4.33
Enterprise value
$133.45M
Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized
Highlights
Utah Medical Products's quick ratio has increased by 37% YoY and by 33% from the previous quarter
UTMD's P/E is 34% below its 5-year quarterly average of 22.3 and 13% below its last 4 quarters average of 17.0
The gross profit has declined by 14% year-on-year and by 5% since the previous quarter
UTMD's revenue is down by 10% year-on-year and by 5% since the previous quarter
Key stats
What are the main financial stats of UTMD
Market
Valuations
Earnings
Shares outstanding
3.48M
Market cap
$222.4M
Enterprise value
$133.45M
Price to earnings (P/E)
14.77
Price to book (P/B)
1.82
Price to sales (P/S)
4.85
EV/EBIT
7.1
EV/EBITDA
5.8
EV/Sales
2.87
Revenue
$46.58M
EBIT
$18.81M
EBITDA
$23.01M
Free cash flow
$18.11M
Per share
Balance sheet
Liquidity
EPS
$4.33
Free cash flow per share
$5.13
Book value per share
$35.16
Revenue per share
$13.19
TBVPS
$31.86
Total assets
$130.03M
Total liabilities
$5.98M
Debt
$275,000
Equity
$124.05M
Working capital
$98.38M
Debt to equity
0
Current ratio
25.98
Quick ratio
23.58
Net debt/EBITDA
-3.87
Margins
Efficiency
Dividend
EBITDA margin
49.4%
Gross margin
59%
Net margin
33.6%
Operating margin
32.7%
Return on assets
11.7%
Return on equity
12.4%
Return on invested capital
96.8%
Return on capital employed
14.9%
Return on sales
40.4%
Dividend yield
1.88%
DPS
$1.2
Payout ratio
27.7%
UTMD stock price
How has the Utah Medical Products stock price performed over time
Intraday
-0.3%
1 week
-1.37%
1 month
-4.41%
1 year
-19.03%
YTD
-24.06%
QTD
-4.41%
Financial performance
How have Utah Medical Products's revenue and profit performed over time
Revenue
$46.58M
Gross profit
$27.48M
Operating income
$15.23M
Net income
$15.63M
Gross margin
59%
Net margin
33.6%
The operating income has contracted by 20% YoY and by 6% from the previous quarter
The gross profit has declined by 14% year-on-year and by 5% since the previous quarter
Utah Medical Products's operating margin has decreased by 11% YoY
UTMD's revenue is down by 10% year-on-year and by 5% since the previous quarter
Growth
What is Utah Medical Products's growth rate over time
Valuation
What is Utah Medical Products stock price valuation
P/E
14.77
P/B
1.82
P/S
4.85
EV/EBIT
7.1
EV/EBITDA
5.8
EV/Sales
2.87
UTMD's P/E is 34% below its 5-year quarterly average of 22.3 and 13% below its last 4 quarters average of 17.0
UTMD's EPS is down by 9% year-on-year and by 4% since the previous quarter
UTMD's price to book (P/B) is 37% lower than its 5-year quarterly average of 2.9 and 17% lower than its last 4 quarters average of 2.2
The equity has contracted by 2.9% from the previous quarter
The stock's P/S is 27% below its 5-year quarterly average of 6.7 and 13% below its last 4 quarters average of 5.6
UTMD's revenue is down by 10% year-on-year and by 5% since the previous quarter
Efficiency
How efficient is Utah Medical Products business performance
UTMD's ROE is down by 17% YoY and by 5% from the previous quarter
Utah Medical Products's return on assets has decreased by 15% YoY and by 4.9% QoQ
Utah Medical Products's ROIC has decreased by 12% YoY and by 4.5% from the previous quarter
Dividends
What is UTMD's dividend history
DPS
$1.2
Dividend yield
1.88%
Payout ratio
27.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Utah Medical Products financials performed over time
Utah Medical Products's quick ratio has increased by 37% YoY and by 33% from the previous quarter
The current ratio has grown by 35% YoY and by 33% from the previous quarter
The debt is 100% lower than the equity
The debt is down by 13% YoY and by 3.5% QoQ
The equity has contracted by 2.9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.